| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/22/2006 | EP1635836A2 Prodrugs of heteroaryl compounds |
| 03/22/2006 | EP1635835A1 2-aminopyrimidine derivatives as raf kinase inhibitors |
| 03/22/2006 | EP1635831A1 Combined use of ecteinascidin-743 and platinum antineoplastic compounds |
| 03/22/2006 | EP1635826A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 03/22/2006 | EP1635808A1 Topical use of valproic acid for the prevention or treatment of skin disorders |
| 03/22/2006 | EP1635798A2 Inhibitors of histone deacetylases for the suppression therapy of diseases |
| 03/22/2006 | EP1635764A2 Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof |
| 03/22/2006 | EP1635641A2 Mitotic kinesin inhibitors |
| 03/22/2006 | EP1549650B1 Substituted c-imidazo[1,2-a]pyridin-3-yl-methylamines |
| 03/22/2006 | EP1497296B1 [1,4]DIAZOCINO[7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS |
| 03/22/2006 | EP1480951A4 Synthesis of indole thiazole compounds as ligands for the ah receptor |
| 03/22/2006 | EP1472221B1 Substituted indoles, method for production and use thereof for the inhibition of pain |
| 03/22/2006 | EP1461436A4 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 03/22/2006 | EP1412357B1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/22/2006 | EP1411817A4 Method and apparatus for the photomodulation of living cells |
| 03/22/2006 | EP1404817B1 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells |
| 03/22/2006 | EP1404319B1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 03/22/2006 | EP1328509B1 Methods of producing oxazolidinone compounds |
| 03/22/2006 | EP1328253B1 Administration of a thiol-based chemoprotectant compound |
| 03/22/2006 | EP1322635B1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 03/22/2006 | EP1313463B1 Fatty acid analogues for the treatment of cancer |
| 03/22/2006 | EP1311522B1 New immunoeffector compounds |
| 03/22/2006 | EP1301516B1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/22/2006 | EP1272488B1 Tri-aryl-substituted-ethane pde4 inhibitors |
| 03/22/2006 | EP1221847A4 Methods of enhancing chemotherapy |
| 03/22/2006 | EP1140840B1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 03/22/2006 | EP1139743B1 Exo-s-mecamylamine formulation and use in treatment |
| 03/22/2006 | EP1107963B1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 03/22/2006 | EP0948356B1 Agent for identifying and treating metastasizing tumours |
| 03/22/2006 | EP0915700B1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 03/22/2006 | EP0914456B1 Gene expression in monocytes and macrophages |
| 03/22/2006 | EP0789564B1 Polynucleotide compositions |
| 03/22/2006 | CN1751061A Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates |
| 03/22/2006 | CN1751059A 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action |
| 03/22/2006 | CN1751052A Therapeutic agents |
| 03/22/2006 | CN1751048A Method for preparing polymorphism of irinotecan hydrochloride |
| 03/22/2006 | CN1751033A Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof |
| 03/22/2006 | CN1751032A Polymorph of {6,7-bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3e) |
| 03/22/2006 | CN1750840A Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 03/22/2006 | CN1750838A Medical drug containing fine particle of noble metal |
| 03/22/2006 | CN1750837A Superoxide anion decomposing agent |
| 03/22/2006 | CN1750823A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/22/2006 | CN1749282A Belly bottom snail polysaccharide and its preparing method |
| 03/22/2006 | CN1749276A Heat shock protein 65-epithelial cell growth factor receptor 2 fusion protein (HSP65-HER2) |
| 03/22/2006 | CN1749268A IIAb18G/CD147 function epitope amino acid sequence of series monoanti-body function and its use |
| 03/22/2006 | CN1748790A Asparaginase injection its preparing method and use |
| 03/22/2006 | CN1748788A Recombinant human interferon alpha 26 injection of prefilled injector package |
| 03/22/2006 | CN1748737A Xiaojin preparation and new preparing method |
| 03/22/2006 | CN1748704A Aqueous preparation for injection and its stabilizing method |
| 03/22/2006 | CN1748674A New use of natural abscisic acid i preparing tumour cell |
| 03/22/2006 | CN1748672A Aseptic medicine composition |
| 03/22/2006 | CN1748671A Slow releasing injection containing anti-mitosis medicine |
| 03/22/2006 | CN1246481C Use of Ard1 gene |
| 03/22/2006 | CN1246458C Human cervical cancer 2 protooncogene and protein encoded therein |
| 03/22/2006 | CN1246336C P28 GANK antibody used for liver cancer identification and diagnosis and its preparation method |
| 03/22/2006 | CN1246333C Receptor in the EDb Fibronection domain |
| 03/22/2006 | CN1246331C Method for purifying recombined human interferon alpha-2b by using affinity chromatography of expanded bed pigment |
| 03/22/2006 | CN1246330C Human tumor generating and metastasis promoting acceptor molecule and its encoding gene and application |
| 03/22/2006 | CN1246329C Mouse tumor generating and metastasis promoting acceptor and its encoding gene and application |
| 03/22/2006 | CN1246328C 17 alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 03/22/2006 | CN1246323C Nitrogen-based camptothecin derivatives |
| 03/22/2006 | CN1246318C Process for preparation of imidazole compounds |
| 03/22/2006 | CN1246315C Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same |
| 03/22/2006 | CN1246311C Pyrrolidines which inhibit CAMP-specific PDE |
| 03/22/2006 | CN1246295C Method and intermediate used for manufacturing antifolic |
| 03/22/2006 | CN1246013C External-applied Chinese medicine for treating external phyma |
| 03/22/2006 | CN1246009C Medicine for treating benign and malignant tumors |
| 03/22/2006 | CN1246004C Medicine for treating tumor |
| 03/22/2006 | CN1245994C Use of salivary lactobacillus |
| 03/22/2006 | CN1245993C Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents |
| 03/22/2006 | CN1245991C Shark meat extract |
| 03/22/2006 | CN1245986C Application of saponin of Bolbostemma paniculatum Franquet for preparing medicine for treating malignant tumor |
| 03/22/2006 | CN1245977C Liposome anti-neoplastic drugs and uses thereof |
| 03/22/2006 | CN1245976C Pharmaceutical formulations in hydroxypropylmenthyl cellulose capsules |
| 03/22/2006 | CN1245971C Tea poly phenol soft capsule and its preparation process |
| 03/22/2006 | CN1245967C Use of compound in making medicine |
| 03/22/2006 | CN1245964C Pharmaceutical composition for preventing and treating cancer and treating an inflammation |
| 03/21/2006 | US7015315 first region having 2'-O-alkyl substituted nucleotide units where the alkyl has at least 2 carbon atoms, and a second region having 2'-deoxy sugar moieties, and which includes phosphorothioate linkages; nuclease resistance; hybridizes to single stranded DNA or RNA |
| 03/21/2006 | US7015241 Appetite-stimulating agents and remedies for anorexia |
| 03/21/2006 | US7015237 Pyridine matrix metalloproteinase inhibitors |
| 03/21/2006 | US7015234 Hydroxamic acid derivatives |
| 03/21/2006 | US7015231 such as (3Z)-3-[(1-methyl-1H-indol-3-yl)methylene]-1,3-dihydro-2H-pyrrolo[3,2-b]pyridin-2-one; tyrosine kinase inhibitors; for treatment of tumor growth, restenosis, atherosclerosis, pain and thrombosis |
| 03/21/2006 | US7015229 An antagonist of a corticotropin releasing factor (CRF) receptor, treating central nervous system disorders or anxiety disorders, depression and stress |
| 03/21/2006 | US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases |
| 03/21/2006 | US7015215 Pyrrolo[2,1-c][1,4] benzodiazepines compounds and process thereof |
| 03/21/2006 | US7015213 Use of diazepines for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 03/21/2006 | US7015016 Use of protein derived from cancer cells, cells infected by a virus or immune cells or an inactive fragment thereof, protein being initially an immunosuppressive and/or angiogenic protein for obtaining medicines to provide mucosal immunity |
| 03/21/2006 | US7014856 for stimulating or enhancing production of an antibody which recognizes a ganglioside; comprises a ganglioside or oligosaccharide portion conjugated to an immunogenic protein with a carrier and/or vehicle; cancer treatment |
| 03/21/2006 | US7014847 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 03/21/2006 | US7014838 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 03/21/2006 | CA2443314C Method of imaging cell death in vivo |
| 03/21/2006 | CA2443214C Vaccine composition comprising human papilloma virus 16 l1 virus-like particle (hpv 16 l1 vlp), human papilloma virus 18 l1 virus-like particle (hpv 18 l1 vlp) and 3-de-o-acylatedmonphosphoryl lipid a (3d-mpl) and alum |
| 03/21/2006 | CA2399358C Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 03/21/2006 | CA2315220C Integrin receptor antagonists |
| 03/21/2006 | CA2270887C Methods and compositions for inhibition of angiogenesis |
| 03/21/2006 | CA2266743C Adenoviral vectors for mutants of human interleukin 6 (hil-6) with hil-6 antagonist activity, pharmaceutical compositions therewith and their uses |
| 03/21/2006 | CA2238816C N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 03/21/2006 | CA2124932C Sex steroid activity inhibitors |
| 03/21/2006 | CA2072416C Cyclopropenone derivatives |
| 03/21/2006 | CA2062792C Treatment of androgen-related diseases |